Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives Behnam Mohammadi-GhalehbinJafar Abbasi ShiranNima Razzaghi-Asl Original Article 24 August 2022 Pages: 1531 - 1545
Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies Palmi ModiShivani PatelMahesh Chhabria Original Article 15 August 2022 Pages: 1547 - 1566
Design, synthesis, graph theoretical analysis and molecular modelling studies of novel substituted quinoline analogues as promising anti-breast cancer agents Prachita Gauns DessaiShivani Prabhu DessaiKunjiappan Selvaraj Original Article 17 August 2022 Pages: 1567 - 1586
Computational studies indicated the effectiveness of human metabolites against SARS-Cov-2 main protease Rajarshi RoyMd Fulbabu SkParimal Kar Original Article 18 August 2022 Pages: 1587 - 1602
Chemical similarity of molecules with physiological response Izudin RedžepovićBoris Furtula Original Article 17 August 2022 Pages: 1603 - 1612
Modeling of MT. P495, an mRNA-based vaccine against the phosphate-binding protein PstS1 of Mycobacterium tuberculosis Sazzad ShahrearAbul Bashar Mir Md. Khademul Islam Original Article 25 August 2022 Pages: 1613 - 1632
Computational design of PD-L1 small molecule inhibitors for cancer therapy Jaikanth ChandrasekaranSenthilkumar ElumalaiPanneerselvam Theivendren Original Article 25 August 2022 Pages: 1633 - 1644
β-Sitosterol could serve as a dual inhibitor of Trypanosoma congolense sialidase and phospholipase A2: in vitro kinetic analyses and molecular dynamic simulations Suleiman AminuAmmar Usman DanazumiMohammed Auwal Ibrahim Original Article 30 August 2022 Pages: 1645 - 1660
Homology modeling of Forkhead box protein C2: identification of potential inhibitors using ligand and structure-based virtual screening Mayar Tarek IbrahimJiyong LeePeng Tao Original Article 01 September 2022 Pages: 1661 - 1674
How effective are ionization state-based QSPKR models at predicting pharmacokinetic parameters in humans? Anish GomatamBlessy JosephEvans Coutinho Original Article 11 October 2022 Pages: 1675 - 1687
Identification of potential inhibitors of Zika virus targeting NS3 helicase using molecular dynamics simulations and DFT studies Shashank Shekher MishraNeeraj KumarSourav Kalra Original Article 05 September 2022 Pages: 1689 - 1701
Design and synthesis of benzimidazole derivatives as apoptosis-inducing agents by targeting Bcl-2 protein Suleyman IlhanÇisil Çamli PulatHarika Atmaca Original Article 05 September 2022 Pages: 1703 - 1712
Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors Yeliz DemirFeyzi Sinan TokalıŞükrü Beydemir Original Article 14 September 2022 Pages: 1713 - 1733
Novel bis-ureido-substituted sulfaguanidines and sulfisoxazoles as carbonic anhydrase and acetylcholinesterase inhibitors Nebih LolakSüleyman AkocakŞükrü Beydemir Original Article 22 September 2022 Pages: 1735 - 1749
Synthesis and molecular docking of new N4-piperazinyl ciprofloxacin hybrids as antimicrobial DNA gyrase inhibitors Hamada H. H. MohammedDoaa Mohamed Elroby AliGamal El-Din A. Abuo-Rahma Original Article Open access 24 September 2022 Pages: 1751 - 1765
Design, combinatorial synthesis and cytotoxic activity of 2-substituted furo[2,3-d]pyrimidinone and pyrrolo[2,3-d]pyrimidinone library Buer SongLifei NieHaji Akber Aisa Original Article 05 October 2022 Pages: 1767 - 1783
Catalyst-free synthesis of acenaphthoindolopyrimidine derivatives Nahale KakavandMohammad BayatYadollah Bayat Original Article 20 September 2022 Pages: 1785 - 1793
Pharmacophoric analogs of sotorasib-entrapped KRAS G12C in its inactive GDP-bound conformation: covalent docking and molecular dynamics investigations Abdul-Quddus Kehinde OyedeleAbdeen Tunde OgunlanaTemitope Isaac Adelusi Original Article 21 October 2022 Pages: 1795 - 1807
Design, synthesis, and pharmacological evaluation of [1, 3] dioxolo-chromeno[2,3-b]pyridines as anti-seizure agents Visarapu MalathiNissi SharonVinod G. Ugale Original Article 10 October 2022 Pages: 1809 - 1827
Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach HemaNandini Rajendran KrishnamoorthyRamanathan Karuppasamy Original Article 10 October 2022 Pages: 1829 - 1842
The regioselective one-pot four-component synthesis of novel functionalized 4H-pyrano[2, 3-b]quinoline derivatives using DABCO as a homogeneous organocatalyst Masumeh HeydariAli Asghar MohammadiMohammadreza Mosleh Short Communication 07 September 2022 Pages: 1843 - 1851
Magnetically recoverable Fe3O4 nanocatalyst for the synthesis of biodynamically significant 1H-pyrazolo[1,2-b]phthalazine-5,10-diones derivatives and its DFT study Mohd Danish AnsariHozeyfa SagirI. R. Siddiqui Short Communication 07 October 2022 Pages: 1853 - 1866
Exploration of NMI-MsCl mediated amide bond formation for the synthesis of novel 3,5-substituted-1,2,4-oxadiazole derivatives: synthesis, evaluation of anti-inflammatory activity and molecular docking studies B. KulkarniK. ManjunathaK. Sunil Short Communication 11 October 2022 Pages: 1867 - 1878
Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices Abdul-Quddus Kehinde OyedeleAbdeen Tunde OgunlanaTope Tunji Odunitan Comprehensive review 04 September 2022 Pages: 1879 - 1903
Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights Nitish KumarAanchal KhannaPreet Mohinder Singh Bedi Comprehensive review 05 October 2022 Pages: 1905 - 1934
Progress in programmed cell death-1/programmed cell death-ligand 1 pathway inhibitors and binding mode analysis Xiaoyun LiQin ZengZhongmei Jiang Short Review 10 August 2022 Pages: 1935 - 1955